Effects of Vitamin D Fortification on Vitamin D Metabolite Profiles and Status in Vitamin D Insufficient Individuals
VITD-2013
A Double-Blind, Randomized, Control Study to Examine the Effects of Vitamin D Fortification on Vitamin D Metabolite Profiles and Status in Vitamin D Insufficient Individuals.
1 other identifier
interventional
N/A
1 country
1
Brief Summary
This is a cross-sectional study designed to compare plasma/serum and urine vitamin D metabolite profiles of vitamin D sufficient and insufficient individuals. There are two phases of this study. Phase 1 - Consented study participants will attend a screening visit and provide a fasting blood and urine sample. Those individuals who are vitamin D insufficient based on serum 25(OH)D concentrations will be invited to participate in Phase II Phase II - is a double-blind, randomized, control study designed to examine vitamin D status in vitamin D insufficient individuals consuming a water-soluble form of vitamin D3. Eligible participants will be asked to consume one of three beverages: i) rooibos iced-tea (control); ii) rooibos iced-tea fortified with 1000 IU of water-soluble vitamin D3; or iii) rooibos iced-tea fortified with 1000 IU of water-soluble vitamin D3 and 360 mg calcium at 240 mL of iced-tea consumed daily for 6 weeks. Participants will attend 6 weekly visits following baseline and provide a fasting blood sample for assessment of serum 25(OH)D concentrations. Objectives: 1) To investigate plasma/serum and urine vitamin D metabolite profiles in vitamin D sufficient and insufficient individuals; and 2) To determine the effects of vitamin D3 fortification on serum 25-dihydroxy-vitamin D \[25(OH)D\] concentrations, markers of vitamin D and calcium metabolism, and vitamin D metabolite profile in plasma/serum and urine of vitamin D insufficient individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jul 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 11, 2015
CompletedFirst Posted
Study publicly available on registry
April 21, 2015
CompletedStudy Start
First participant enrolled
July 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2018
CompletedFebruary 23, 2017
March 1, 2016
1.9 years
February 11, 2015
February 22, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Plasma/Serum and Urine Vitamin D Metabolite Profiles of Vitamin D Sufficient and Insufficient Individuals
To investigate plasma/serum and urine vitamin D metabolite profiles in vitamin D sufficient and insufficient individuals.
Screening Visit (Day 0) - Phase 1
The Effects of Vitamin D Fortification on Serum 25(OH)D in Vitamin D Insufficient Individuals.
To determine the effects of 6 weeks of vitamin D3 fortification on serum 25-dihydroxy-vitamin D \[25(OH)D\] concentrations of vitamin D insufficient individuals.
6 Weeks (Phase II)
Secondary Outcomes (3)
The Effects of Vitamin D3 Fortification on markers of vitamin D of vitamin D insufficient individuals
6 Weeks (Phase II)
The Effects of vitamin D3 Fortification on calcium metabolism of Vitamin D Insufficient Individuals.
6 Weeks (Phase II)
The Effects of Vitamin D3 Fortification on Vitamin D Metabolite Profile of Vitamin D Insufficient Individuals.
6 Weeks (Phase II)
Study Arms (3)
Control
PLACEBO COMPARATORParticipants will be instructed to consume 240 mL of iced-tea daily for 6 weeks. The iced-tea beverages do not contain added sugar or artificial sweeteners. Beverages will be prepared fresh weekly and picked up by participants during their weekly study visits.
Rooibos Tea - Vitamin D3
ACTIVE COMPARATORParticipants will be instructed to consume 240 mL of iced-tea fortified with 1000 IU water-soluable vitamin D3 daily for 6 weeks. The iced-tea beverages do not contain added sugar or artificial sweeteners. Beverages will be prepared fresh weekly and picked up by participants during their weekly study visits.
Rooibos Tea- Vitamin D3 & Calcium
ACTIVE COMPARATORParticipants will be instructed to consume 240 mL of Rooibos iced-tea fortified with 1000 IU of water-soluable vitamin D3 and 360 mg of calcium daily for 6 weeks. The iced-tea beverages do not contain added sugar or artificial sweeteners. Beverages will be prepared fresh weekly and picked up by participants during their weekly study visits.
Interventions
Participants will consume 240 mL of Rooibos iced-tea daily for 6 weeks. The iced-tea beverage will not contain any added sugar or artificial sweeteners. Beverages will be prepared fresh weekly and picked up by participants during their weekly study visits.
Participants will consume 240 mL of Rooibos iced-tea fortified with 1000 IU of water soluable Vitamin D3 daily for 6 weeks. The iced-tea beverage will not contain any added sugar or artificial sweeteners. Beverages will be prepared fresh weekly and picked up by participants during their weekly study visits.
Participants will consume 240 mL of Rooibos iced-tea fortified with 1000 IU of water soluable Vitamin D3 and 360 mg of Calicum daily for 6 weeks. The iced-tea beverage will not contain any added sugar or artificial sweeteners. Beverages will be prepared fresh weekly and picked up by participants during their weekly study visits.
Eligibility Criteria
You may qualify if:
- Adult volunteers, male or female, between 19 and 50 years of age;
- Body mass index (BMI) ≥20 and ≤30 kg/m2 (normal to overweight);
- Must be on a stable regime for the past three months, if taking vitamin and mineral/dietary/herbal supplements; and
- Willing to provide informed consent.
- Adult volunteers, male or female, between 19 and 50 years of age;
- Body mass index (BMI) ≥20 and ≤30 kg/m2 (normal to overweight);
- Must be on a stable regime for the past three months, if taking vitamin and mineral/dietary/herbal supplements;
- Vitamin D insufficient (serum 25(OH)D concentrations ≥30 and ≤75 nmol/L);
- Willing to comply with protocol requirements; and
- Willing to provide informed consent.
You may not qualify if:
- Take a vitamin D or calcium supplement within the last three months before the start date of the study, or during the study;
- History of vitamin D deficiency (serum 25(OH)D concentration \<30 nmol/L);
- History of hypocalcaemia;
- Presence of a clinically diagnosed disease affecting the circulatory, respiratory, immune, skeletal, urinary, muscular, endocrine, digestive, nervous or reproductive system that requires medical treatment;
- Taking any medication (with the exception of birth control);
- Daily consumption of more than three servings of dairy products;
- Undergone significant sun exposure one month before start date of the study;
- Use or have used a tanning booth one month before start date of the study, or during the study;
- Plan to travel to a sunny climate during the study;
- Currently smoking or have smoked within the last six months before start date of the study, or during the study;
- Have allergies to tea products;
- Pregnant or lactating; and
- Consume excessive alcohol (\>10 drinks/week for women, \>15 drinks/week for men).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St. Boniface Hospital, Asper Clinical Research Institute
Winnipeg, Manitoba, R2H 2A6, Canada
Related Publications (5)
Calvo MS, Whiting SJ, Barton CN. Vitamin D fortification in the United States and Canada: current status and data needs. Am J Clin Nutr. 2004 Dec;80(6 Suppl):1710S-6S. doi: 10.1093/ajcn/80.6.1710S.
PMID: 15585792BACKGROUNDTangpricha V, Koutkia P, Rieke SM, Chen TC, Perez AA, Holick MF. Fortification of orange juice with vitamin D: a novel approach for enhancing vitamin D nutritional health. Am J Clin Nutr. 2003 Jun;77(6):1478-83. doi: 10.1093/ajcn/77.6.1478.
PMID: 12791627BACKGROUNDDing S, Schoenmakers I, Jones K, Koulman A, Prentice A, Volmer DA. Quantitative determination of vitamin D metabolites in plasma using UHPLC-MS/MS. Anal Bioanal Chem. 2010 Sep;398(2):779-89. doi: 10.1007/s00216-010-3993-0. Epub 2010 Jul 14.
PMID: 20628873BACKGROUNDLuque de Castro MD, Fernandez-Romero JM, Ortiz-Boyer F, Quesada JM. Determination of vitamin D3 metabolites: state-of-the-art and trends. J Pharm Biomed Anal. 1999 Jun;20(1-2):1-17. doi: 10.1016/s0731-7085(99)00027-8.
PMID: 10704005BACKGROUNDStalmach A, Mullen W, Pecorari M, Serafini M, Crozier A. Bioavailability of C-linked dihydrochalcone and flavanone glucosides in humans following ingestion of unfermented and fermented rooibos teas. J Agric Food Chem. 2009 Aug 12;57(15):7104-11. doi: 10.1021/jf9011642.
PMID: 19534535BACKGROUND
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carla Taylor, PhD
University of Manitoba
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 11, 2015
First Posted
April 21, 2015
Study Start
July 1, 2016
Primary Completion
June 1, 2018
Study Completion
June 1, 2018
Last Updated
February 23, 2017
Record last verified: 2016-03